---
title: "IQVIA: Business Model & Revenue Engine"
description: "IQVIA revenue by business segment and geography from its fiscal 2025 Form 10-K, with each part's share, growth and profitability explained."
canonical: https://www.getswoopr.com/stocks/companies/iqvia/business-model/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# IQVIA: Business Model & Revenue Engine

## Direct Answer

IQVIA reports revenue across 3 business segments in its fiscal 2025 Form 10-K. Research and Development Solutions is the largest, with $8.9 billion of revenue (55% of the total), followed by Technology and Analytics Solutions at $6.6 billion (41%).

## How Does IQVIA Make Money?

No single line supplies a majority of revenue: the largest, Research and Development Solutions, is 55%, which spreads IQVIA's exposure across several demand drivers. Between fiscal 2024 and 2025, Contract Sales and Medical Solutions grew fastest (+9.7%) and Research and Development Solutions slowest (+4.3%), so the revenue mix tilts toward Contract Sales and Medical Solutions while that gap lasts.

| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| Research and Development Solutions | $8.9 billion | $8.5 billion | 54.5% | 4.3% |
| Technology and Analytics Solutions | $6.6 billion | $6.2 billion | 40.6% | 7.6% |
| Contract Sales and Medical Solutions | $788 million | $718 million | 4.8% | 9.7% |

![Bar chart of IQVIA revenue by segment for fiscal 2025: Research and Development Solutions 54.5%, Technology and Analytics Solutions 40.6%, Contract Sales and Medical Solutions 4.8%.](https://www.getswoopr.com/images/charts/iqvia-business-model-segment-mix.webp)
*IQVIA revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.*

## Where Does IQVIA's Revenue Come From?

Regions follow the definitions in the filing; most companies assign revenue by customer location.

| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| Americas | $7.7 billion | $7.4 billion | 47.5% | 5.3% |
| EMEA | $5.2 billion | $4.9 billion | 31.8% | 5.4% |
| Asia Pacific | $3.4 billion | $3.1 billion | 20.7% | 8.0% |

## What the Segment Figures Do Not Show

The rows above add up to 100% of IQVIA's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

## Where These Numbers Come From

Every figure on this page is a value IQVIA reported in the segment note and revenue disclosures of its Form 10-K filed February 17, 2026 (accession 0001628280-26-008322), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

## Frequently Asked Questions

### What are IQVIA's business segments?

In its fiscal 2025 Form 10-K, IQVIA reports revenue for Research and Development Solutions, Technology and Analytics Solutions and Contract Sales and Medical Solutions.

### Which part of IQVIA brings in the most revenue?

Research and Development Solutions, with $8.9 billion of revenue in fiscal 2025, or 55% of the total.

### Where does IQVIA report its segment results?

In the segment note to the financial statements in its Form 10-K, most recently filed February 17, 2026, alongside management's discussion of each segment's results.

## References

- [SEC EDGAR: IQVIA HOLDINGS INC. Form 10-K filed February 17, 2026](https://www.sec.gov/Archives/edgar/data/1478242/000162828026008322/iqv-20251231.htm)
- [SEC EDGAR: IQVIA HOLDINGS INC. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1478242&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)
- [SEC: Financial Statement Data Sets](https://www.sec.gov/data-research/sec-markets-data/financial-statement-data-sets)

## Related Pages

- [IQVIA company dossier](https://www.getswoopr.com/stocks/companies/iqvia/)
- [IQVIA financial metrics](https://www.getswoopr.com/stocks/companies/iqvia/metrics/)
- [IQVIA financial risk indicators](https://www.getswoopr.com/stocks/companies/iqvia/risks/)
- [IQVIA peer comparison](https://www.getswoopr.com/stocks/companies/iqvia/competitors/)
- [IQVIA business model and revenue mix](https://www.getswoopr.com/stocks/companies/iqvia/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).